Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Highly Accessed Open Badges Study protocol

Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)

Roman Hájek*, Richard Bryce, Sunhee Ro, Barbara Klencke and Heinz Ludwig

BMC Cancer 2012, 12:415  doi:10.1186/1471-2407-12-415

Article Metrics

Total accesses

Article metric FAQ


  • Last 30 days: 88 accesses
  • Last 365 days: 877 accesses
  • All time: 4232 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Open Badges